Articles

5-HT3 Receptor Antagonists: New Promising Therapeutic Agents in Diabetes and Its Complications

Carvalho F, Marcedo D, Banderia I, Maldonado I, Salles L, Azevedo MF, Rocha MA Jr, Fregoneze JB, De Castroe- Silva E. Central 5-HT3 receptor stimulation by m-CPBG increases blood glucose in rats. Horm Metabol Res 2002;34:55–61.

Heimes K, Feistel B, Verspohl EJ. Impact of the 5-HT3 receptor channel system for insulin secretion and interaction of ginger extracts. Eur J of Pharmacol 2009;624:58–65.

Fakhfouri G, Rahimian R, Ghia JE, Khan WI, Dehpour AR. Impact of 5-HT3 receptor antagonists on peripheral and central diseases. Drug Discov Today 2012;17(13-14):741-7.

Rahimian R, Dehpour AR, Fakhfouri G, Khorramizadehc MR,, Ghiad JE, Seyedabadia M, Caldarellie A, Mousavizadehf K, Forouzandehg M, Ejtemaei Mehr Sh. Tropisetron Upregulates Cannabinoid CB1 Receptors in Cerebellar Granule Cells: Possible Involvement of Calcineurin. Brain Res 2011;1417:1–8.

Norouzi A, Fakhfouri G, Rahimian R. How Can 5-HT3 Receptor Antagonists Exert Analgesic Properties? Acta Med Iran 2012;50(4):225.

Eisensamer B, Rammes G, Gimpl G, Shapa M, Ferrari U, Hapfelmeier G, Bondy B, Parsons C, Gilling K, Zieglgänsberger W, Holsboer F, Rupprecht R. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Molecul Psychiatry 2003;8:994–1007.

Files
IssueVol 51, No 10 (2013) QRcode
SectionArticles
 
Keywords
No Keywords##

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Rahimian R, Ejtemaei Mehr S, Fakhfouri G, Dehpour AR. 5-HT3 Receptor Antagonists: New Promising Therapeutic Agents in Diabetes and Its Complications. Acta Med Iran. 51(10):736.